In the Green: Longboard Pharmaceuticals Inc (LBPH) Closes at 33.89, Up/Down 1.47 from Previous Day

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Longboard Pharmaceuticals Inc (NASDAQ: LBPH) closed at $33.89 up 1.47% from its previous closing price of $33.40. In other words, the price has increased by $1.47 from its previous closing price. On the day, 1.87 million shares were traded. LBPH stock price reached its highest trading level at $35.04 during the session, while it also had its lowest trading level at $33.44.

Ratios:

For a deeper understanding of Longboard Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.95 and its Current Ratio is at 20.95. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on September 10, 2024, initiated with a Buy rating and assigned the stock a target price of $60.

On July 01, 2024, Cantor Fitzgerald reiterated its Overweight rating and also lowered its target price recommendation from $60 to $90.

On May 01, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $36.Robert W. Baird initiated its Outperform rating on May 01, 2024, with a $36 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 16 ’24 when Kaye Randall sold 16,666 shares for $31.64 per share. The transaction valued at 527,318 led to the insider holds 17,920 shares of the business.

RANDALL KAYE bought 33,333 shares of LBPH for $1,143,989 on Sep 16 ’24. On Jan 23 ’24, another insider, Kaye Randall, who serves as the CMO of the company, bought 100 shares for $24.82 each. As a result, the insider paid 2,482 and bolstered with 100 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LBPH now has a Market Capitalization of 1318304000 and an Enterprise Value of 1017293760.

Stock Price History:

Over the past 52 weeks, LBPH has reached a high of $40.48, while it has fallen to a 52-week low of $3.60. The 50-Day Moving Average of the stock is -2.90%, while the 200-Day Moving Average is calculated to be 45.83%.

Shares Statistics:

For the past three months, LBPH has traded an average of 681.84K shares per day and 842220 over the past ten days. A total of 38.90M shares are outstanding, with a floating share count of 33.57M. Insiders hold about 13.69% of the company’s shares, while institutions hold 99.70% stake in the company. Shares short for LBPH as of 1724976000 were 4759758 with a Short Ratio of 6.98, compared to 1722384000 on 4959631. Therefore, it implies a Short% of Shares Outstanding of 4759758 and a Short% of Float of 16.17.

Most Popular